Open company graph database — free web & API
Login

Fujirebio China Co., Ltd.

瑞必欧(上海)诊断技术有限公司 [Fujirebio China Co., Ltd. ]瑞必欧(上海)診断技術有限公司 [富士レビオ中国株式会社]Alias瑞必欧(上海)诊断技术有限公司Alias
Ticker
—
Listed market
—
Country
China
Employees (non-consolidated)
—
Related companies
5
§01

Basic information

BASIC
Head office
Room 3302, Building A, Gubei SOHO, 188 Hongbao Road, Changning District, Shanghai, China
Chief executive
Employees (non-consolidated)
Employees (consolidated)
Start date
End date
§02

Websites

1 DOMAINS
§03

Business

187
CDMO (OEM)NeuroHPVAFP AntibodiesAMH ControlAmpFire® HPV High Risk GenotypingAmpFire® HPV Screening 16/18/HRAmyloid-β AntibodiesAntigensAuto-LIA™ 48Auto-LiPA™ 48BACE-1 AntibodiesBD-Tau AntibodiesBorrelia Line ImmunoblotC50 AntibodiesCA125 AntibodiesCA15-3 AntibodiesCA19-9 - AntibodiesCEA AntibodiesCanAg® AFP EIACanAg® CA125 EIACanAg® CA15-3 EIACanAg® CA19-9 EIACanAg® CA242™ EIACanAg® CEA EIACanAg® Free PSA EIACanAg® Glypican-3 EIACanAg® NSE EIACanAg® PSA EIACanAg® ProGRP EIACanAg® S100 EIACanAg® SCC EIACanChek™DOPA Decarboxylase AntibodiesDYNABLOT HEATDiaPlexQ™ ApoE Genotyping KitDiaPlexQ™ COVID-19 (N, ORF1a) Detection KitDiaPlexQ™ Flu A/B & SARS-CoV-2 Detection KitDiaPlexQ™ SARS-CoV-2 (N, ORF1a, RdRp) Fast Detection KitEBV LINE ImmunoblotFITC Anti-Rabies Monoclonal GlobulinFree PSA AntibodiesFuc-GM1 AntibodyHE4 EIAHIV-1, p24HPV-Risk assayIL-6 (Interleukin) LPGINNO-LIA® ANA UpdateINNO-LIA® HCV ScoreINNO-LIA® HIV I/II ScoreINNO-LIA® HTLV I/II ScoreINNO-LIA® Syphilis ScoreINNO-LiPA® CFTRiageINNO-LiPA® HBV GenotypingINNO-LiPA® HCV 2.0 ControlINNO-LiPA® HCV 2.0 GenotypingINNO-LiPA® HPV Genotyping Extra IIINNOTEST® HCV Ab IVINNOTEST® HIV Antigen mAbINNOTEST® PHOSPHO-TAU (181P)INNOTEST® PHOSPHO-TAU(181P)INNOTEST® hPLAPINNOTEST® hTAU AgINNOTEST® β-AMYLOID(1-40)INNOTEST® β-AMYLOID(1-42)Infectious disease antigens, HIV, HTLV, HCVInfectious disease antigens, SyphilisLIRAS® for LIPA® HBVLUMIPULSE® G1200LUMIPULSE® G600IILiRAS® for Infectious DiseasesLiRAS® for LIA® ANALiRAS® for LiPA HCVLiRAS® for LiPA® Cystic FibrosisLiRAS® for LiPA® HBVLiRAS® for LiPA® HLALiRAS® for LiPA® HPVLumipulse® ApoE4 ControlsLumipulse® B.R.A.H.M.S PCT ControlsLumipulse® G 25-OH Vitamin DLumipulse® G ADxPLORER® BD-TauLumipulse® G ADxPLORER® DDCLumipulse® G ADxPLORER® NPTX2Lumipulse® G ADxPLORER® NeurograninLumipulse® G ADxPLORER® VAMP2Lumipulse® G ADxPLORER® pTau231Lumipulse® G ADxPLORER® α-SynucleinLumipulse® G ADxPLORER® β-SynucleinLumipulse® G AFP-N (Alpha-Fetoprotein)Lumipulse® G AMH (anti-Müllerian hormone)Lumipulse® G AldosteroneLumipulse® G ApoE4Lumipulse® G B•R•A•H•M•S PCTLumipulse® G GFAPLumipulse® G HBcAb-NLumipulse® G HBcrAgLumipulse® G HMW AdiponectinLumipulse® G KL-6 (Krebs von den Lungen)Lumipulse® G MesothelinLumipulse® G NfL BloodLumipulse® G NfL Blood ControlsLumipulse® G NfL CSFLumipulse® G PIVKA-IILumipulse® G Pan-ApoELumipulse® G ReninLumipulse® G Total TauLumipulse® G pTau 181Lumipulse® G pTau 181 PlasmaLumipulse® G pTau 217 CSFLumipulse® G pTau 217 PlasmaLumipulse® G sTREM2Lumipulse® G whole PTHLumipulse® G β-Amyloid 1-40Lumipulse® G β-Amyloid 1-40 PlasmaLumipulse® G β-Amyloid 1-42Lumipulse® G β-Amyloid 1-42 PlasmaLumipulse® GFAP ControlsLumipulse® HBcrAg ControlsLumipulse® NfL Blood ControlsLumipulse® NfL CSF ControlsLumipulse® PIVKA-II and KL-6 ControlsLumipulse® PTH ControlsLumipulse® Renin ControlsLumipulse® SARS-CoV-2 Ag ControlsLumipulse® Total Tau ControlsLumipulse® pTau 181 ControlsLumipulse® pTau 181 Plasma ControlsLumipulse® pTau 217 CSF ControlsLumipulse® pTau 217 Plasma ControlLumipulse® pTau 217 Plasma ControlsLumipulse® sTREM2 ControlsLumipulse® β-Amyloid ControlsLumipulse® β-Amyloid Plasma ControlsLung Marker ControlMesothelin ControlMic qPCRNPTX2 AntibodiesNSE AntibodiesNeurofilament Light chain AntibodiesNeurogranin AntibodiesOther AntibodiesPHF-Tau AntibodiesPower-Gene 9600 PlusPreCursor-M AnoGYNPreCursor-M+RoboBlot™S100/S100BB/S100A1B AntibodiesSample Extraction SolutionSero Lumipulse IA control L1 and L2Seronorm™️ Immunoassay Lyo L-1Seronorm™️ Immunoassay Lyo L-2Soluble TREM-2 AntibodiesSynuclein AntibodiesTENDIGO™Tau AntibodiesThrombosis biomarkers, D-DimerTotal PSA AntibodiesTotal Tau AntibodiesTreponema pallidum LINE ImmunoblotTumor Marker ControlVAMP2 AntibodiesYersinia enterocolitica LINE ImmunoblotiAMP COVID-19 Detection KitiAMP COVID-19 SANO AssaypTau AntibodiesAlzheimer's disease testing solutionsHPV testingAntibody Identification and CharacterizationAntibody SupplyContract ManufacturingProduct DevelopmentClinical ServicesRegulatory ServicesPlasma Services Group provides sera and other samples for materials of control reagents and calibratCritical and high quality biological raw materials for IVD and life science industriesIVD testing technologiesunique biomarkersdiagnostic solutionsNeuro Center of ExcellenceNExT - the Neuro Expert ToolboxCollection, screening and supply of high quality and rare biological materials required for R&D and Provision of sera and other samples for control reagents and calibrators for a wide range of diseaseSample collection services globallyCDMO partnershipsDiagnostic Tools for Alzheimer’s DiseaseMedical EducationThe Fujirebio Neuro Center of Excellence
§04

Related companies

5 COMPANIES
Company name Group Parent Subsidiary Customer Supplier Alliance Bank Shareholder
Fujirebio Inc.
Fujirebio Holdings, Inc.
H.U. Group Holdings Inc.
H.U. Group Holdings Inc.
Plasma Services Group
Names without a link are companies not yet registered in OpenBizGraph
§05

Network

NETWORK
Drag to move · click to open
§06

History

18 EVENTS

Fujirebio (formerly Fujizoki Pharmaceutical, Co., Inc.) is founded in Tokyo, Japan.Sources

Launch of HA Ag (TPHA), the world’s first hemagglutination test for syphilis.Sources

Launch of the syphilis SERODIA®-TP•PA test kit, destined to become a gold standard.Sources

Established Fujirebio Taiwan Inc.Sources

Established Fujirebio America, Inc. (merged to Fujirebio Diagnostics, Inc.) in USA.Sources

Established Fujirebio Holdings, Inc., as parent company of Fujirebio Inc., Fujirebio Diagnostics, Inc., Fujirebio Europe N.V. and other Fujirebio group companies.Sources

Launched Lumipulse G β-Amyloid 1-42Sources

Established Fujirebio Diagnostics Japan, Inc., focusing on OEM business in Japan.Sources

Established Fujirebio China Co., Ltd.Sources

Launched Lumipulse G β-Amyloid 1-42.Sources

Centocor Diagnostics in 1998Sources

Centocor Diagnostics in 1998.Sources

CanAg Diagnostics in 2006Sources

CanAg Diagnostics in 2006.Sources

Advanced Life Science Institute, Inc. and American Biological Technologies, Inc. in 2008.Sources

Innogenetics in 2010Sources

Innogenetics in 2010.Sources

ADx NeuroSciences and Fluxus, Inc. in 2022.Sources

§07

News

0 ARTICLES

There is no news.

§09

Sources & updates

SOURCES
↑